CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Evaluation the diagnostic and prognostic value of cytokeratin-19 (ck19) gene expression in Iraqi breast cancer patients

Author: 
Abdul Hussein M. AL-Faisal, Jawdat N. Gaaib, Nada Al-Alwan and Mohammed Ghanim
Subject Area: 
Health Sciences
Abstract: 

Breast cancer is the most frequent carcinoma in females and the second most common cause of cancer related mortality in women. Early detection of breast cancer is widely reported to be one of the most effective ways leading to better prognosis and lower death rate. For marker discovery, the analysis of mRNA expression signatures in peripheral human blood has been widely used showing to be a promising technique. Cytokeratin-19 (CK 19) is a novel gene that was diagnosed as a highly specific marker for primary breast cancer. The aim of the present study is detecting the expression levels of the CK-19 gene mRNAs in the peripheral blood of breast cancer patients in comparison with benign and healthy controls as a tool for screening and diagnosis the early stage breast cancers, and estimating the diagnostic and prognostic values of these levels in association with tumor size and lymph node status. The marker was determined in peripheral blood (PB) of 55 patients with Invasive Ductal Carcinoma and samples from 20 healthy donors, and 10 women with newly diagnosed benign breast tumors were served as control group using reverse transcriptase polymerase chain reaction (RT-PCR). CK-19 was detected in 41(74.54%) peripheral blood of breast cancer patients while 14(25.46%) patients were CK 19-negative. CK-19 also detected in, 1(10%) of the benign tumors and 2(10%) of healthy individuals. It showed statistically significant relations with size of the tumor, and Lymph node involvement. On the other hand, it was statistically non-significant for age of breast cancer patients. The present study results suggest that CK-19 is a specific molecular marker for detection of breast cancer, discrimination between benign and malignant breast tumors, and it might be of value as a prognostic marker.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran